Optiver Holding B.V. Inmune Bio, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 158 shares of INMB stock, worth $238. This represents 0.0% of its overall portfolio holdings.
Number of Shares
158Holding current value
$238% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INMB
# of Institutions
97Shares Held
6.31MCall Options Held
1.51MPut Options Held
3.34M-
Vanguard Group Inc Valley Forge, PA876KShares$1.32 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.23 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$900,52145.87% of portfolio
-
Geode Capital Management, LLC Boston, MA469KShares$708,8540.0% of portfolio
-
Ubs Group Ag449KShares$678,3230.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $27.1M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...